🟢 Chimeric Therapeutics is trading 7.69% up today with no clear company-specific announcement

Chimeric Therapeutics is trading 7.69% up at A$0.01 on August 26, 2026, with no new company-specific announcement clearly explaining the gain.

• On August 19, the company stopped CHM-2101 enrolment and dosing after dose-limiting toxicities, saying the therapy would not progress in its current form.
• Shares declined 25.00% on August 24 and 45.71% on August 19, highlighting ongoing volatility.